These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5020354)

  • 41. Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Parker CJ; Wiedmer T; Sims PJ; Rosse WF
    J Clin Invest; 1985 Jun; 75(6):2074-84. PubMed ID: 4008653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Erythrocyte membrane defects and asymmetry in paroxysmal nocturnal hemoglobinuria and myelodysplastic syndrome.
    Basu S; Banerjee D; Ghosh M; Chakrabarti A
    Hematology; 2010 Aug; 15(4):236-9. PubMed ID: 20670483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxidative status of red blood cells, neutrophils, and platelets in paroxysmal nocturnal hemoglobinuria.
    Amer J; Zelig O; Fibach E
    Exp Hematol; 2008 Apr; 36(4):369-77. PubMed ID: 18261835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Immunophenotyping study on the blood cells of the patients with paroxysmal nocturnal hemoglobinuria].
    Chen G; Shao Z; Jia H; Chu Y; Shen D; Zhang Y; Zhang J
    Zhonghua Xue Ye Xue Za Zhi; 1997 Apr; 18(4):190-2. PubMed ID: 15622765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of the enhanced susceptibility of paroxysmal nocturnal hemoglobinuria erythrocytes to complement-mediated hemolysis initiated by cobra venom factor.
    Parker CJ; Stone OL; Bernshaw NJ
    J Immunol; 1989 Jan; 142(1):208-16. PubMed ID: 2909615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria.
    Kozuma Y; Sawahata Y; Takei Y; Chiba S; Ninomiya H
    Br J Haematol; 2011 Mar; 152(5):631-9. PubMed ID: 21241275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and evaluation of a stabilized whole-blood preparation as a process control material for screening of paroxysmal nocturnal hemoglobinuria by flow cytometry.
    Richards SJ; Whitby L; Cullen MJ; Dickinson AJ; Granger V; Reilly JT; Hillmen P; Barnett D
    Cytometry B Clin Cytom; 2009 Jan; 76(1):47-55. PubMed ID: 18777525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glycopeptides of erythrocyte membranes in some hematological disorders.
    Balduini CL; Tira ME; Ascari E; Balduini C
    Acta Haematol; 1976; 55(5-2):282-8. PubMed ID: 821292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of "PNH red cell" populations in hematological disorders using the Sephacryl Gel Test micro typing system.
    Meletis J; Michali E; Samarkos M; Konstantopoulos K; Meletis C; Terpos E; Tsimberidou A; Chandrinou E; Viniou N; Rombos Y; Pangalis GA; Yataganas X; Loukopoulos D
    Leuk Lymphoma; 1997 Dec; 28(1-2):177-82. PubMed ID: 9498717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Evaluation and quantification of complement-sensitive red cells in PNH and aplastic anemia-PNH syndrome].
    Shichishima T; Terasawa T; Uchida T; Kariyone S
    Rinsho Ketsueki; 1989 Mar; 30(3):297-302. PubMed ID: 2769953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5430-4. PubMed ID: 6225118
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor.
    Medof ME; Kinoshita T; Silber R; Nussenzweig V
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2980-4. PubMed ID: 2581259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cation transport in normal human red cells treated with sulfhydryl compounds.
    D'Amico G; Sirchia G; Ferrone S; Romagnoni M
    Experientia; 1966 Jan; 22(1):32-3. PubMed ID: 5915131
    [No Abstract]   [Full Text] [Related]  

  • 54. The erythrocyte acetylcholinesterase enzyme in paroxysmal nocturnal hemoglobinuria.
    AUDITORE JV; HARTMANN RC; FLEXNER JM; BALCHUM OJ
    Arch Pathol; 1960 May; 69():534-43. PubMed ID: 13795052
    [No Abstract]   [Full Text] [Related]  

  • 55. [Changing complement sensitivity and PNH red cell population during the clinical course in a case of PNH with hypoplastic bone marrow].
    Shichishima T; Yoshida M; Terasawa T; Konno I; Mita M; Uchida T; Kariyone S
    Rinsho Ketsueki; 1987 Apr; 28(4):564-9. PubMed ID: 3626048
    [No Abstract]   [Full Text] [Related]  

  • 56. Erythrocyte vesiculation in paroxysmal nocturnal hemoglobinuria.
    Pan H; Ji Z; Liu E; Zhang Z
    Chin Med Sci J; 1991 Jun; 6(2):84-6. PubMed ID: 1725134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paroxysmal nocturnal hemoglobinuria. II. Erythrocyte acetylcholinesterase defect.
    AUDITORE JV; HARTMANN RC
    Am J Med; 1959 Sep; 27():401-10. PubMed ID: 13795054
    [No Abstract]   [Full Text] [Related]  

  • 58. Potential errors in the laboratory diagnosis of paroxysmal nocturnal hemoglobinuria.
    Harruff RC; Rohn RJ
    Am J Clin Pathol; 1983 Aug; 80(2):152-8. PubMed ID: 6881089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paroxysmal nocturnal hemoglobinuria (PNH) as a clonal disorder.
    Hartmann RC; Arnold AB
    Annu Rev Med; 1977; 28():187-94. PubMed ID: 324358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cephalothin-treated normal red cells: a new type of PNH-like cells.
    Sirchia G; Mercuriali F; Ferrone S
    Experientia; 1968 May; 24(5):495-6. PubMed ID: 5674999
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.